Pfizer's rare heart disease drug succeeds in late-stage study
(Reuters) - Pfizer Inc's experimental drug to treat a rare and fatal disease linked to heart failure reduced deaths and need for hospitalizations in a late-stage study.
from Reuters: Health News https://ift.tt/2J5EhSX
from Reuters: Health News https://ift.tt/2J5EhSX
Comments
Post a Comment